Northern Trust’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-107,568
| Closed | -$120K | – | 4484 |
|
|
2025
Q2 | $120K | Sell |
107,568
-79,398
| -42% | -$97K | ﹤0.01% | 4071 |
|
|
2025
Q1 | $215K | Sell |
186,966
-6,019
| -3% | -$11.2K | ﹤0.01% | 3922 |
|
|
2024
Q4 | $1.18M | Buy |
192,985
+1,312
| +0.7% | +$15.6K | ﹤0.01% | 3317 |
|
|
2024
Q3 | $3.17M | Buy |
191,673
+56,946
| +42% | +$624K | ﹤0.01% | 2725 |
|
|
2024
Q2 | $926K | Sell |
134,727
-2,509
| -2% | -$21.5K | ﹤0.01% | 3281 |
|
|
2024
Q1 | $1.32M | Buy |
137,236
+440
| +0.3% | +$5.1K | ﹤0.01% | 3181 |
|
|
2023
Q4 | $1.14M | Buy |
136,796
+1,013
| +0.7% | +$5.88K | ﹤0.01% | 3269 |
|
|
2023
Q3 | $1.13M | Buy |
135,783
+15,009
| +12% | +$127K | ﹤0.01% | 3250 |
|
|
2023
Q2 | $1.11M | Buy |
120,774
+1,974
| +2% | +$22.1K | ﹤0.01% | 3319 |
|
|
2023
Q1 | $1.63M | Sell |
118,800
-1,248
| -1% | -$25.8K | ﹤0.01% | 3026 |
|
|
2022
Q4 | $2.04M | Buy |
120,048
+6,399
| +6% | +$128K | ﹤0.01% | 2983 |
|
|
2022
Q3 | $2.58M | Buy |
113,649
+3,043
| +3% | +$61.4K | ﹤0.01% | 2879 |
|
|
2022
Q2 | $1.99M | Buy |
110,606
+25,934
| +31% | +$462K | ﹤0.01% | 3072 |
|
|
2022
Q1 | $2.26M | Buy |
84,672
+7,128
| +9% | +$133K | ﹤0.01% | 3041 |
|
|
2021
Q4 | $2.27M | Sell |
77,544
-2,970
| -4% | -$148K | ﹤0.01% | 3164 |
|
|
2021
Q3 | $5.29M | Sell |
80,514
-21,740
| -21% | -$1.66M | ﹤0.01% | 2692 |
|
|
2021
Q2 | $8.51M | Sell |
102,254
-877
| -0.9% | -$65K | ﹤0.01% | 2485 |
|
|
2021
Q1 | $7.91M | Sell |
103,131
-11,738
| -10% | -$1.07M | ﹤0.01% | 2454 |
|
|
2020
Q4 | $10.1M | Sell |
114,869
-5,078
| -4% | -$357K | ﹤0.01% | 2241 |
|
|
2020
Q3 | $8.85M | Sell |
119,947
-15,605
| -12% | -$924K | ﹤0.01% | 2180 |
|
|
2020
Q2 | $9.89M | Buy |
135,552
+45,692
| +51% | +$2.78M | ﹤0.01% | 2103 |
|
|
2020
Q1 | $5.05M | Buy |
89,860
+17,183
| +24% | +$753K | ﹤0.01% | 2298 |
|
|
2019
Q4 | $2.77M | Buy |
+72,677
| New | +$1.83M | ﹤0.01% | 2930 |
|
Other funds holding IGMS
Northern Trust's IGMS Position: Q3 2025 in Review
Northern Trust sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 107,568 shares — an estimated $120K sold.
Northern Trust first reported a position in IGMS in Q4 2019 and held it in 23 quarters. The position peaked at $10.1M in Q4 2020. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- Northern Trust reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- Northern Trust sold 107,568 IGM Biosciences shares in Q3 2025, an estimated $120K.
- Northern Trust first reported a position in IGM Biosciences in Q4 2019 and held it in 23 quarters.
- Northern Trust's IGM Biosciences position peaked at $10.1M in Q4 2020.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.